160 related articles for article (PubMed ID: 8522307)
41. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors.
Shiao YH; Rice JM; Anderson LM; Diwan BA; Hard GC
J Natl Cancer Inst; 1998 Nov; 90(22):1720-3. PubMed ID: 9827526
[TBL] [Abstract][Full Text] [Related]
42. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
43. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
[TBL] [Abstract][Full Text] [Related]
44. Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours.
Foster K; Osborne RJ; Huddart RA; Affara NA; Ferguson-Smith MA; Maher ER
Eur J Cancer; 1995 Dec; 31A(13-14):2392-5. PubMed ID: 8652274
[TBL] [Abstract][Full Text] [Related]
45. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
46. Unilateral Papillary Cystadenoma of the Epididymis as a First Presentation of Von Hippel-Lindau Disease.
Miscia ME; Di Renzo D; Persico A; Tarallo L; Chiesa PL
Urology; 2018 Aug; 118():189-191. PubMed ID: 29729363
[TBL] [Abstract][Full Text] [Related]
47. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
[TBL] [Abstract][Full Text] [Related]
48. Papillary cystadenoma of the epididymis. Case report and review of the literature.
Wernert N; Goebbels R; Prediger L
Pathol Res Pract; 1986 May; 181(2):260-4. PubMed ID: 3737482
[TBL] [Abstract][Full Text] [Related]
49. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
[TBL] [Abstract][Full Text] [Related]
50. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
[TBL] [Abstract][Full Text] [Related]
51. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
52. [Papillary cystadenoma of epididymis].
Peyrí Rey E; Casalots Serramia J
Actas Urol Esp; 2000 Oct; 24(9):761-3. PubMed ID: 11132450
[TBL] [Abstract][Full Text] [Related]
53. Identification of somatic mutations in the von Hippel-Lindau (VHL) gene in a patient with renal cell carcinoma.
Wang WC; Chen HJ; Tseng YH; Lai YC
J Formos Med Assoc; 2009 Nov; 108(11):886-93. PubMed ID: 19933033
[TBL] [Abstract][Full Text] [Related]
54. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
[TBL] [Abstract][Full Text] [Related]
55. Ultrasound demonstration of a papillary cystadenoma of the epididymis.
Alexander JA; Lichtman JB; Varma VA
J Clin Ultrasound; 1991 Sep; 19(7):442-5. PubMed ID: 1658073
[No Abstract] [Full Text] [Related]
56. Papillary cystadenoma of epididymis: component of von Hippel-Lindau syndrome.
Gruber MB; Healey GB; Toguri AG; Warren MM
Urology; 1980 Sep; 16(3):305-6. PubMed ID: 7423716
[TBL] [Abstract][Full Text] [Related]
57. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
58. Epididymal cystadenomas and epithelial tumourlets: effects of VHL deficiency on the human epididymis.
Gläsker S; Tran MG; Shively SB; Ikejiri B; Lonser RR; Maxwell PH; Zhuang Z; Oldfield EH; Vortmeyer AO
J Pathol; 2006 Sep; 210(1):32-41. PubMed ID: 16841375
[TBL] [Abstract][Full Text] [Related]
59. Third International Meeting on von Hippel-Lindau disease.
Zbar B; Kaelin W; Maher E; Richard S
Cancer Res; 1999 May; 59(9):2251-3. PubMed ID: 10232616
[TBL] [Abstract][Full Text] [Related]
60. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]